A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Prospective, multicenter, single arm, phase II study, to evaluate the efficacy of the combination rituximab-golcadomide as a chemo free approach in a population of older patients with new diagnosis of DLBCL, defined as frail according to a sGA evaluation and not candidate for the standard R-CHOP (or R-CHOP like) treatments.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Nowo rozpoznany chłoniak B-ogniskowy (DLBCL) - nigdy wcześniej nieleczony
- •Wiek 80 lat lub więcej i/lub osłabienie zdolności do samodzielnego funkcjonowania
- •Pacjent nie kwalifikuje się do standardowego intensywnego leczenia chemią
- •Chłoniak w stadium I-IV
- •Możliwość zmierzenia zmian chłoniaka (powiększone węzły co najmniej 1,5 cm)
- •Wystarczająca liczba krwinek białych, płytek krwi i hemoglobiny
- •Prawidłowa funkcja nerek i wątroby
- •Zdolność do regularnego uczęszczania na wizyty i przyjmowania leków
Simplified criteria — AI translation
Trial details
- Minimum age
- 80 Years
- Last updated (source)
- August 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (20)
AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria - SCDU Ematologia
Alessandria, Italy
Azienda Sanitaria Locale di Pescara- Presidio Ospedaliero Santo Spirito - U.O.C. Ematologia
Pescara, Italy
AOU Ospedali Riuniti - Clinica di Ematologia
Ancona, Italy
Azienda Ospedaliera S. Giuseppe Moscati - S.C. Ematologia e trapianto emopoietico
Avellino, Italy
Ospedale IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuno-correlati
Aviano, Italy
ASST Spedali Civili di Brescia - Ematologia
Brescia, Italy
Azienda Ospedaliera Universitaria Careggi -Unità Funzionale di Ematologia
Florence, Italy
ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia
Milan, Italy
Fondazione IRCCS San Gerardo dei Tintori -Ematologia
Monza, Italy
I.R.C.C.S. Istituto Oncologico Veneto -Oncologia 1
Padova, Italy
Policlinico Giaccone - Ematologia
Palermo, Italy
Azienda USL Piacenza - UOC Ematologia e Centro Trapianti,
Piacenza, Italy
Ospedale delle Croci - Ematologia
Ravenna, Italy
Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia
Reggio Emilia, Italy
Ematologia - Trapianto cellule staminali - Medicina Trasfusionale e Terapie Cellulari, Policlinico Universitario Campus Bio-Medico
Roma, Italy
AOU Senese - U.O.C. Ematologia
Siena, Italy
A.O.U. Città della Salute e della Scienza di Torino - Ematologia Universitaria
Torino, Italy
A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia
Torino, Italy
Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - S.C. Ematologia
Trieste, Italy
AOU Integrata di Verona - U.O. Ematologia
Verona, Italy
Trial contact
Uffici Studi FIL
Uffici Studi FIL
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/25/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.